Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' Income from Continuing Operations rose 4775.57% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 580.51%. This contributed to the annual value of -$10.7 million for FY2024, which is 3039.44% up from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Income from Continuing Operations stood at -$1.4 million, which was up 4775.57% from -$4.0 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Income from Continuing Operations high stood at -$1.4 million for Q3 2025, and its period low was -$4.6 million during Q4 2021.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$3.4 million (2021), whereas its average is -$3.4 million.
  • The largest annual percentage gain for Ekso Bionics Holdings' Income from Continuing Operations in the last 5 years was 4775.57% (2025), contrasted with its biggest fall of 6770.44% (2025).
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Income from Continuing Operations stood at -$4.6 million in 2021, then increased by 1.87% to -$4.5 million in 2022, then grew by 21.92% to -$3.5 million in 2023, then skyrocketed by 34.88% to -$2.3 million in 2024, then skyrocketed by 37.96% to -$1.4 million in 2025.
  • Its Income from Continuing Operations was -$1.4 million in Q3 2025, compared to -$4.0 million in Q2 2025 and -$3.5 million in Q1 2025.